Camber Capital Management LP Q3 2022 vs. Q4 2022 13F Holdings Comparison

Camber Capital Management LP is a top-performing hedge fund, managing over $2.5 billion in assets. They are known for their focus on the healthcare industry and their success in generating alpha from their investments. In this article, we will analyze the changes in their holdings for Q3 2022 compared to Q4 2022.

Firstly, we can see that Camber Capital Management decreased their holdings in some of the big names in the pharma industry. For example, they reduced their holdings in Viatris Inc. by 12.9%, from 30 million shares to 20 million shares. Viatris is a global healthcare company focused on improving access to medicines. Camber Capital also decreased their holdings in Myriad Genetics Inc. by only 6.5%, from 50 million shares to 70 million shares. Myriad Genetics is a leading personalized medicine company.

On the other hand, Camber Capital Management held onto their healthcare bets in other companies. They increased their stake in Walgreens Boots Alliance Inc. by a whopping 110.6%, from 2.825 million shares to 5 million shares. Walgreens is one of the largest drugstore chains in the world.

Another company that caught Camber Capital Management's attention was Quanterix Corp. Camber Capital increased their position in the company by 43.5%, from 3 million shares to 3.425 million shares. Quanterix Corp. is a company that specializes in developing ultra-sensitive diagnostic tests.

Camber Capital Management also made significant investments in the senior living and fitness industries. They increased their stake in Brookdale Seniors Living Inc. by 12.5%, from 16 million shares to 18 million shares. Brookdale is a senior living community with over 700 communities in 42 states. Camber Capital also reduced their stake in Peloton Interactive Inc. by 23.6%, from 3 million shares to 2 million shares. Peloton is a fitness company that offers live and on-demand workouts from their stationary bikes.

In conclusion, Camber Capital Management LP manages their positions carefully, with a focus on the healthcare industry. They have made strategic decisions to hold onto some of their flagship companies, while reducing their positions in others. With a diversified portfolio, Camber Capital Management is in a good position to continue to generate alpha for their investors.